Cannabis Bioscience International Holdings (CBIH) Gains from Investment Securities (2024 - 2025)
Cannabis Bioscience International Holdings' (CBIH) quarterly Gains from Investment Securities came in at $24570.0 in Q1 2025, up 402.1% quarter-over-quarter from -$8133.0 in Q4 2024.
Cannabis Bioscience International Holdings (CBIH) Gains from Investment Securities (2024 - 2025) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Gains from Investment Securities across 2 years of filings, most recently posting $24570.0 for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2025 | 24,570.00 |
| Feb 28, 2025 | 24,570.00 |
| Nov 30, 2024 | -8,133.00 |
| Nov 30, 2024 | -8,133.00 |
| Aug 31, 2024 | 8,133.00 |
| Aug 31, 2024 | 8,133.00 |